Bisphosphonate-Associated Osteonecrosis of the Jaws and Endodontic Treatment: Two Case Reports
- 1 October 2005
- journal article
- case report
- Published by Elsevier in Journal of Endodontics
- Vol. 31 (10) , 759-763
- https://doi.org/10.1097/01.don.0000182737.09980.2c
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Osteonecrosis of the Jaw and BisphosphonatesNew England Journal of Medicine, 2005
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Jaw avascular bone necrosis associated with long-term use of biphosphonatesAnnals of Oncology, 2005
- Bisphosphonate-associated oral osteonecrosisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2005
- Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 casesJournal of Oral Pathology & Medicine, 2005
- Intravenous bisphosphonates and osteonecrosisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Osteonecrosis of the maxilla and mandible: possible drug-induced complication of bisphosphonate therapyOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic AcidThe Journal of Pharmacology and Experimental Therapeutics, 2002